cryptocurrency earnings- Top People searches

On December 4, the price of pig food was 7.74, up 0.52% from November 27. According to the data of the National Development and Reform Commission, as of December 4, the price of live pigs nationwide was 16.72 yuan/kg, down 1.30% from November 27. The price of corn in the main wholesale market is 2.16 yuan/kg, down 1.82% from November 27; The price of pig food was 7.74, up 0.52% from November 27th.Cantor Fitzgerald, the nominee of Trump Secretary of Commerce, was fined by the SEC, and the US Securities and Exchange Commission (SEC) sued Cantor Fitzgerald, a financial services company, for allegedly violating the regulatory disclosure regulations related to the Special Purpose Acquisition Company (SPAC) before raising funds. Cantor agreed to settle the SEC's allegations with a civil fine of $6.75 million, and agreed not to violate the relevant laws and regulations again, but the company did not admit or deny the relevant allegations. It is worth noting that Howard Lutnick, Chairman and CEO of Cantor, was recently nominated by US President-elect Trump as the Secretary of Commerce, and Lutnick is also the co-chairman of Trump's transition team.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.

FTSE China A50 index futures opened 0.80% lower, and closed down 0.89% in the last session.The three major stock indexes opened lower, with the Shanghai Composite Index down 0.54%, the Shenzhen Component Index down 0.74% and the Growth Enterprise Market down 0.87%.Pengyue Automobile Development Co., Ltd., a subsidiary of Tucki, was forced to enforce 680,000 yuan. According to the risk information of Tianyan, recently, Guangzhou Pengyue Automobile Development Co., Ltd. and Hunan Chunqiu Engineering Co., Ltd. added a piece of information about the person to be executed, with an execution target of more than 684,000 yuan, involving construction contract disputes. The enforcement court is Tianhe District People's Court of Guangzhou. Guangzhou Pengyue Automobile Development Co., Ltd. was established in August 2021, with the legal representative of Zhao Dawu and the registered capital of 1.88 billion RMB. Its business scope includes auto parts retail, tire sales, investment activities with its own funds, electric vehicle charging infrastructure operation, industrial design service and motor vehicle charging sales, etc. It is wholly owned by Guangzhou Xpeng Motors Technology Co., Ltd.

The weighted share price index of Taiwan Stock Exchange opened 0.2% lower at 23,002.37.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.Zongheng Communication established a new science and technology company in Zhejiang. The enterprise search APP shows that recently, Zongheng Cross-border Technology (Zhejiang) Co., Ltd. was established with Xu Shasha as its legal representative and a registered capital of 10 million yuan. Its business scope includes: sales of information security equipment; Network equipment sales; Internet of things technical services, etc. Enterprise equity penetration shows that the company is wholly owned by Zongheng Communication.